TY  - GEN
AU  - Braig,Friederike
AU  - Voigtlaender,Minna
AU  - Schieferdecker,Aneta
AU  - Busch,Chia-Jung
AU  - Laban,Simon
AU  - Grob,Tobias
AU  - Kriegs,Malte
AU  - Knecht,Rainald
AU  - Bokemeyer,Carsten
AU  - Binder,Mascha
TI  - Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
SN  - 1949-2553
PY  - 2018///0109
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cetuximab
KW  - administration & dosage
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Fluorouracil
KW  - GTP Phosphohydrolases
KW  - Head and Neck Neoplasms
KW  - High-Throughput Nucleotide Sequencing
KW  - methods
KW  - Humans
KW  - Liquid Biopsy
KW  - Membrane Proteins
KW  - Mutation
KW  - drug effects
KW  - Platinum
KW  - Proto-Oncogene Proteins p21(ras)
KW  - ras Proteins
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.8943
ER  -